Biomarker to predict target drug efficacy for hepatocellular carcinoma and its use

摘要

Present application discloses a combination and the use of the marker or markers that can distinguish a patient with refractory patients with high discrimination conforming to seashell penip drug. Marker according to herein simply as a non-invasive test by the blood can be determined whether or not compliance with Hermit penip, reducing drug side effects, can be personalized custom drug administration based this, of course, has a number of advantages in reducing cost .;